Tatsuo Hosoya Selected Research

Tatsuo Hosoya Research Topics

Disease

32	Gout 11/2021 - 01/2008
31	Hyperuricemia 01/2022 - 01/2008
25	Chronic Renal Insufficiency 01/2022 - 01/2003
16	Hypertension (High Blood Pressure) 11/2021 - 11/2002
15	Chronic Kidney Failure (Chronic Renal Failure) 06/2013 - 01/2002
13	Proteinuria 01/2022 - 01/2003
10	Diabetic Nephropathies (Diabetic Nephropathy) 08/2018 - 11/2002
9	Cardiovascular Diseases (Cardiovascular Disease) 12/2013 - 12/2005
7	Secondary Hyperparathyroidism 12/2018 - 09/2002
7	IGA Glomerulonephritis (IGA Nephropathy) 08/2013 - 01/2007
6	Glomerulonephritis 01/2013 - 01/2003
6	Fibrosis (Cirrhosis) 11/2012 - 01/2008
5	Peritoneal Fibrosis 02/2014 - 01/2002
5	Anemia 10/2012 - 11/2002
5	Renal Insufficiency (Renal Failure) 01/2012 - 10/2002
4	Drug-Related Side Effects and Adverse Reactions 12/2018 - 06/2011
4	Gouty Arthritis 12/2018 - 01/2014
3	Diabetes Mellitus 04/2016 - 06/2003
3	Sclerosis 05/2014 - 01/2007
3	Body Weight (Weight, Body) 05/2014 - 02/2011
3	Acute Kidney Injury (Acute Renal Failure) 01/2013 - 12/2008
3	Type 2 Diabetes Mellitus (MODY) 01/2013 - 11/2002
3	Interstitial Nephritis (Tubulointerstitial Nephritis) 06/2012 - 01/2005
3	Nephritis 04/2012 - 01/2005
3	Vascular Calcification 01/2012 - 06/2003
3	Renal hypouricemia 12/2008 - 01/2004
3	Hypercalcemia (Milk Alkali Syndrome) 12/2004 - 07/2002
2	Juvenile gout 08/2015 - 06/2008
2	Albuminuria 08/2015 - 06/2012
2	Kidney Diseases (Kidney Disease) 08/2014 - 01/2007
2	Atherosclerosis 12/2013 - 12/2005
2	Obesity 11/2013 - 01/2008
2	Hemorrhage 01/2013 - 07/2011
2	Virus Diseases (Viral Diseases) 07/2012 - 12/2011
2	Vasculitis (Vasculitides) 06/2012 - 01/2007
2	Inflammation (Inflammations) 01/2012 - 10/2010
2	Neoplasms (Cancer) 12/2011 - 01/2006
2	Nephrotic Syndrome (Syndrome, Nephrotic) 07/2011 - 07/2010
2	Wounds and Injuries (Trauma) 11/2010 - 01/2007
2	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 07/2010 - 01/2006
2	Hyperphosphatemia 01/2009 - 07/2002
2	Autosomal Dominant Polycystic Kidney (ADPKD) 09/2008 - 01/2005
2	Eosinophilia 01/2008 - 05/2004

Drug/Important Bio-Agent (IBA)

41	Uric Acid (Urate)IBA 01/2022 - 01/2004
14	Febuxostat FDA Link 01/2022 - 06/2011
12	CreatinineIBA 01/2022 - 10/2002
12	Angiotensin Receptor AntagonistsIBA 01/2012 - 10/2002
11	urate transporterIBA 08/2021 - 01/2004
11	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2003
9	dotinuradIBA 12/2021 - 03/2020
9	Xanthine OxidaseIBA 01/2021 - 06/2011
9	Antihypertensive Agents (Antihypertensives)IBA 01/2018 - 11/2002
9	Allopurinol (Remid)FDA LinkGeneric 03/2017 - 01/2002
8	purineIBA 01/2021 - 06/2004
8	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2012 - 11/2002
7	Pharmaceutical PreparationsIBA 03/2020 - 01/2005
5	AlbuminsIBA 01/2021 - 10/2010
5	FYX-051IBA 12/2018 - 12/2014
5	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2010 - 11/2002
4	BenzbromaroneIBA 08/2021 - 01/2004
4	Vitamin D FDA LinkGeneric 12/2018 - 07/2002
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2012 - 01/2005
4	CalciumIBA 01/2012 - 09/2002
4	PotassiumIBA 06/2006 - 10/2002
3	C-Reactive ProteinIBA 01/2021 - 10/2012
3	CholesterolIBA 04/2016 - 06/2003
3	MineralsIBA 08/2014 - 08/2004
3	Warfarin (Coumadin)FDA LinkGeneric 01/2013 - 01/2007
3	SaltsIBA 06/2012 - 01/2003
3	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 06/2012 - 01/2007
3	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 04/2012 - 02/2011
3	Losartan (Cozaar)FDA LinkGeneric 04/2012 - 10/2002
3	AldosteroneIBA 03/2012 - 06/2006
3	Parathyroid Hormone (Parathormone)IBA 01/2012 - 12/2004
3	Phosphates (Orthophosphate)IBA 05/2010 - 09/2002
3	AngiotensinsIBA 12/2009 - 06/2006
3	DiureticsIBA 12/2005 - 01/2003
2	ORALIT (ORS)IBA 10/2019 - 04/2016
2	Calcitriol Receptors (Calcitriol Receptor)IBA 12/2018 - 01/2012
2	Xanthine DehydrogenaseIBA 08/2018 - 03/2017
2	Member 2 Subfamily G ATP Binding Cassette TransporterIBA 01/2017 - 01/2014
2	UromodulinIBA 08/2015 - 06/2008
2	Amlodipine (Norvasc)FDA LinkGeneric 10/2014 - 01/2005
2	Hemoglobins (Hemoglobin)IBA 01/2014 - 12/2013
2	SteroidsIBA 08/2013 - 10/2012
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2012 - 01/2007
2	candesartanIBA 02/2011 - 01/2005
2	Calcineurin InhibitorsIBA 11/2010 - 07/2010
2	ReninIBA 12/2009 - 06/2006
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 03/2009 - 12/2004
2	Creatine Kinase (Creatine Phosphokinase)IBA 12/2008 - 01/2002
2	Erythropoietin FDA Link 06/2008 - 03/2007

Therapy/Procedure

29	Therapeutics 01/2022 - 11/2002
15	Renal Dialysis (Hemodialysis) 12/2018 - 01/2002
6	Peritoneal Dialysis 02/2014 - 01/2002
6	Transplantation 09/2012 - 07/2003
5	Kidney Transplantation 07/2011 - 01/2005
4	Drug Therapy (Chemotherapy) 01/2014 - 12/2008
3	Continuous Ambulatory Peritoneal Dialysis (CAPD) 06/2012 - 05/2002
3	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2009 - 06/2002